Cancers linked to inherited mutations

Most cancers are thought to arise because of changes that occur during the lifetime of the affected person.  Some cancer have been linked to defective (mutant) genes that are inherited from the person's parent(s).  The cancer itself is not inherited, but the defective genes make it more likely that particular cancers will occur.  Families with these genes can have much more cancer than others.

The National Cancer Institute’s list of common cancer-related inherited genetic mutations includes mutations that affect several different tumor suppressorA gene that functions in the control of cell division. Tumor suppressors normally work to limit cell division and may be contrasted with oncogenes. genes. The cancers caused by inherited changes to tumor suppressor genes include breast cancer, ovarian cancer, prostate cancer, leukemiaA cancer affecting the cells that develop into white or red blood cells. Both of these cell types originate from stem cells in bone marrow. Red blood cells function to carry oxygen to our tissues and the white cells (leukocytes) are part of our immune system. The cancerous cells often accumulate in the blood., pancreatic cancer, and colon cancer.1, 2, 3

NOTE: Only a portion of each of these cancer types is linked to inherited mutations. The rest of the cases are called ‘sporadic’, and they are not  hereditary.

Many cancers are now routinely tested to see if they are candidates for treatment with targeted drugs. This includes some of those linked to hereditary cancer syndromes and a growing list of other cancers.

Because the cancers on the list below can be due to inherited geneA stretch of DNA that leads to the production of an RNA. The RNA is produced during the process of transcription. This RNA can be used to guide the formation of a protein via translation or can be used directly in the cell. mutations, many people diagnosed with them chose to get tested to see if they  have the gene of interest. 4, 5

Learn about genetic testing at the Winship Cancer Institute of Emory University.

Learn more about targeted cancer treatments.

Below are short descriptions of some of the better understood hereditary cancers:

Hereditary Breast Cancer
Li-Fraumeni syndrome
Cowden syndrome
Lynch syndrome
Familial Adenomatous PolyposisAlso: FAP. An inherited form of colon cancer characterized by the development of hundreds to thousands of colonic polyps. Most of these polyps are harmless but some eventually progress to malignant growths. FAP is often diagnosed via colonoscopy.
RetinoblastomaA cancer of the retina. Found most often in small children; this disease has been linked to the inheritance of mutated copies of the Rb tumor suppressor gene. For more information, see the entries on Rb and Tumor Suppressor.
Multiple Endocrine Neoplasia
Von-Hippel Lindau Syndrome


  • 1. Cancer.gov website: Genetic testing fact sheet. Reviewed April 2013. [http://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet]
  • 2. Larki P, Khoshbakht S, Rezaei N. Genetics of neoplasia: inherited monogenic defects associated with cancers. Acta Med Iran. 2014;52(1):91-2. [PUBMED]
  • 3. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008 Nov 13;359(20):2143-53. [PUBMED]
  • 4. NIH Genetics Home Resource: Genetic Testing. Published August 3, 2015 [http://ghr.nlm.nih.gov/handbook/testing/procedure]
  • 5. NCI - Genetic Testing for Hereditary Cancer Syndromes Reviewed April 2013 [http://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet]
  • 6.a. b. Tiwari AK, Roy HK, Lynch HT. Lynch Syndrome in the 21st Century: Clinical Perspectives. QJM. 2015 Jul 29. pii: hcv137. [Epub ahead of print] [PUBMED]
  • 7.a. b. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010 Jun;138(6):2073-2087 [PUBMED]
  • 8.a. b. NIH Genetics Home Reference: Lynch Syndrome Published 08-03-1025 [http://ghr.nlm.nih.gov/condition/lynch-syndrome]
  • 9. Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugières L, Caron O, Benusiglio PR, Bressac-de Paillerets B, Bonadona V, Bonaïti-Pellié C, Tinat J, Baert-Desurmont S, Frebourg T. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. J Clin Oncol. 2015 Jul 20;33(21):2345-52. Epub 2015 May 26. [PUBMED]
  • 10. Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Vilar E. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015 Jul 20. pii: JCO.2015.61.4503. [Epub ahead of print] [PUBMED]
  • 11. Merino D, Malkin D. p53 and hereditary cancer. Subcell Biochem. 2014;85:1-16. [PUBMED]
  • 12. Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L. Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes. Biomed Res Int. 2015;2015:341723. Epub 2015 May 17. [PUBMED]
  • 13. PTEN. From the NIH Genetics Home Reference. Published August 3, 2015 [http://ghr.nlm.nih.gov/gene/PTEN]
  • 14. Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S, Cognetti F, Ciuffreda L. PTEN: Multiple Functions in Human Malignant Tumors. Front Oncol. 2015 Feb 16;5:24. [PUBMED]
  • 15. Haas NB, Nathanson KL. Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis. 2014 Jan;21(1):81-90 [PUBMED]
  • 16. NIH Genetics Home Reference: APC Reviewed March 2013, Published 8-3-2915 [http://ghr.nlm.nih.gov/gene/APC]
  • 17. NIH Genetics Home Reference. Familial Adenomatous Polyposis Reviewed October 2013, Published August 3, 2015 [http://ghr.nlm.nih.gov/condition/familial-adenomatous-polyposis]
  • 18. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009 Oct 12;4:22. [PUBMED]
  • 19. Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003 Dec 12;2:41. [PUBMED]
  • 20. NIH Genetics Home Reference: Retinoblastoma. Reviewed August 2009, Published August 3, 2015 [http://ghr.nlm.nih.gov/condition/retinoblastoma]
  • 21. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006 Aug 28;25(38):5220-7. [PUBMED]
  • 22. Lohmann DR, Gallie BL. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. 2000 Jul 18 [updated 2013 Mar 28] [PUBMED]
  • 23. Berger AH, Knudson AG, Pandolfi PP. A continuum model for tumour suppression. Nature. 2011 Aug 10;476(7359):163-9. [PUBMED]
  • 24. Field M, Shanley S, Kirk J. Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health. 2007 Apr;43(4):219-29. [PUBMED]
  • 25. NIH Genetics Home Resource: MEN1 Reviewed August 2013, Published August 3, 2015 [http://ghr.nlm.nih.gov/gene/MEN1]
  • 26. Gaztambide S, Vazquez F, Castaño L. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1). Minerva Endocrinol. 2013 Mar;38(1):17-28. [PUBMED]
  • 27.a. b. Carney JA. Familial multiple endocrine neoplasia: the first 100 years. Am J Surg Pathol. 2005 Feb;29(2):254-74. [PUBMED]
  • 28.a. b. Anik A, Abaci A. Endocrine cancer syndromes: an update. Minerva Pediatr. 2014 Dec;66(6):533-47. Epub 2014 Sep 22. [PUBMED]
  • 29.a. b. Sovrea AS, Dronca E, Galatâr M, Radian S, Vornicescu C, Georgescu C. Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review. Rom J Morphol Embryol. 2014;55(2):389-400. [PUBMED]
  • 30.a. b. NIH Genetics Home Reference - Multiple Endocrine Neoplasia. Reviewed August 2013, Published August 3, 2015 [http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia]
  • 31. Jessica Marquard, MS, LGC and Charis Eng, MD, PhD, FACP. Multiple Endocrine Neoplasia Type 2, Synonyms: MEN 2, MEN2 Syndrome NCBI Gene Reviews - Initial Posting: September 27, 1999; Last Update: June 25, 2015. [http://www.ncbi.nlm.nih.gov/books/NBK1257/]
  • 32. Kaelin WG Jr. "Molecular basis of the VHL hereditary cancer syndrome." Nat Rev Cancer (2002). 2(9):673-82. [PUBMED]
  • 33. Cowey CL, Rathmell WK. VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy. Curr Oncol Rep. 2009 Mar;11(2):94-101. [PUBMED]
  • 34. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010 Jun;221(2):125-38. doi: 10.1002/path.2689. [PUBMED]
  • 35. VHL. Genetics Home Reference. National Institutes of Health. U.S. Department of Health and Human Services. Reviewed August 2012, Published August 2015 [http://ghr.nlm.nih.gov/gene/VHL]
  • 36. Shahzad H, Kehar SI, Ali S, Tariq N. Expression of Von Hippel - Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma. Pak J Med Sci. 2014 Jul;30(4):880-5. [PUBMED]